Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The combination of venetoclax, daratumumab and dexamethasone for the treatment of refractory primary plasma cell leukemia.

× No keyword cloud information.

6 in total

Review 1. A clinical perspective on plasma cell leukemia; current status and future directions.

Authors: Sherilyn A Tuazon; Leona A Holmberg; Omar Nadeem; Paul G Richardson
Journal: Blood Cancer J Date: 2021-02-04 Impact factor: 11.037

2. Bortezomib-Based Regimens and Plasma Cell Leukemia

Authors: Ali Zahit Bolaman
Journal: Turk J Haematol Date: 2021-01-19 Impact factor: 1.831

3. Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers.

Authors: Virág Réka Szita; Gábor Mikala; András Kozma; János Fábián; Apor Hardi; Hussain Alizadeh; Péter Rajnics; László Rejtő; Tamás Szendrei; László Váróczy; Zsolt Nagy; Árpád Illés; István Vályi-Nagy; Tamás Masszi; Gergely Varga
Journal: Pathol Oncol Res Date: 2022-02-28 Impact factor: 3.201

Review 4. Update on primary plasma cell leukemia.

Authors: Sung-Hoon Jung; Je-Jung Lee
Journal: Blood Res Date: 2022-04-30

Review 5. Practical management and assessment of primary plasma cell leukemia in the novel agent era.

Authors: A Visram; A Suska; A Jurczyszyn; W I Gonsalves
Journal: Cancer Treat Res Commun Date: 2021-06-08

6. Real-world data on safety and efficacy of venetoclax-based regimens in relapsed/refractory t(11;14) multiple myeloma.

Authors: Diana Basali; Rajshekhar Chakraborty; Lisa Rybicki; Nathaniel Rosko; Janice Reed; Maryann Karam; Kristen Schlueter; Hayley Dysert; Matt Kalaycio; Jason Valent
Journal: Br J Haematol Date: 2020-02-03 Impact factor: 8.615

6 in total